Well Health - Digitale Services für die Medizin (Seite 2)
eröffnet am 12.11.22 11:39:23 von
neuester Beitrag 21.05.24 15:48:53 von
neuester Beitrag 21.05.24 15:48:53 von
Beiträge: 109
ID: 1.364.777
ID: 1.364.777
Aufrufe heute: 5
Gesamt: 8.553
Gesamt: 8.553
Aktive User: 0
ISIN: CA94947L1022 · WKN: A2JQV6 · Symbol: W7V
2,5390
EUR
-0,90 %
-0,0230 EUR
Letzter Kurs 16:11:59 Tradegate
Neuigkeiten
| TitelBeiträge |
|---|
21.03.24 · IRW Press |
30.11.23 · IRW Press |
14.11.23 · IRW Press |
Werte aus der Branche Finanzdienstleistungen
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 9,2700 | +47,14 | |
| 5,8039 | +22,96 | |
| 12,300 | +19,42 | |
| 13,140 | +14,01 | |
| 10,540 | +13,21 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 83,59 | -11,82 | |
| 1,4500 | -13,69 | |
| 1,0000 | -16,67 | |
| 1,1000 | -18,52 | |
| 10,500 | -39,38 |
Beitrag zu dieser Diskussion schreiben
Feedback
Das sind gute Nachrichten. Also umtriebig sind die ja. Da kann man echt nichts sagen. Bin mal gespannt ob die ihre KI Firma mit einbinden. Das würde einen erheblichen Mehrwert bringen. Denke so günstig wird mal bald keine Stücke mehr bekommen. NmM
good news ...
WELL Health Technologies Announces Collaboration with Microsoft to Accelerate Healthcare's Digital TransformationThe collaboration aims to improve North American healthcare by integrating Microsoft Azure and its AI with WELL's digital health platform to improve clinical outcomes, optimize costs, and ensure top-tier data privacy and security.
The integration is expected to streamline WELL's cloud and infrastructure environments and position it to improve its ability to scale and offer leading edge solutions across all of its business units, with an emphasis on Canada.
VANCOUVER, BC, April 30, 2024 /CNW/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or "the Company"), a company focused on positively impacting health outcomes by leveraging technology to empower healthcare providers and their patients globally, is pleased to announce it is collaborating with Microsoft to accelerate healthcare's digital transformation. This five-year agreement is set to accelerate the digital transformation of healthcare delivery across North America and beyond, integrating Microsoft Cloud and AI capabilities with WELL's comprehensive digital health platform to innovate and enhance the healthcare experience for both providers and patients. A key focus will be to substantially elevate WELL's scalability and flexibility as part of its offerings, especially as its organic growth accelerates and it aims to help large enterprise clients such as those in public sector.
...
https://www.newswire.ca/news-releases/well-health-technologi…
Sehe das auch langfristig werde bei entsprechenden Kursen weiter aufstocken 😀
Down 15% Since Earnings: Is WELL Health a Good Stock to Buy?
Despite the near-term weakness, WELL Health offers excellent buying opportunities for long-term investors, given the expanding addressable markets and attractive valuation.
WELL Health Technologies (TSX:WELL) is a tech-enabled healthcare company that focuses on technologies and services to aid healthcare providers in improving patient outcomes. Last month, the company reported underwhelming fourth-quarter earnings, with its adjusted net income declining by 10%. The company’s lower-than-expected 2024 guidance weighed on its stock price. It has lost 14.6% of its stock value since reporting its fourth-quarter earnings and is trading at a discount of 40% compared to its 52-week high.
So, let’s assess whether the recent correction offers any buying opportunities in the stock by looking at its recent performance and growth prospects.
WELL’s fourth-quarter performance
In the fourth quarter, WELL Health’s revenue grew 48% to $231.2 million. The acquisitions over the last four quarters, solid organic growth in its virtual businesses, and higher patient visits at its primary care drove its top line. Amid the top-line growth, its gross profits increased by 26%. However, its gross margins fell 760 basis points to 43.7% amid increased lower-margin recruitment-related revenue.
Meanwhile, the company’s net income increased from $22.1 million to $33.8 million. However, after removing special items, its adjusted net income stood at $11.16 million, representing a 10.7% decline from the previous year’s quarter. Also, its adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) stood at $30.8 million, a 13% increase from the previous year’s quarter. The company ended 2023 with cash and cash equivalents of $43.4 million, representing an 11.2% decline from the prior year’s quarter. Now, let’s look at its growth prospects.
WELL’s growth prospects
The digitization of clinical procedures and the growing popularity of virtual healthcare services have created a multi-year growth potential for WELL Health. Meanwhile, the Vancouver-based company has continued its expansion by signing an agreement to acquire 10 primary care medical clinics in Ontario and British Columbia from Shoppers Drug Mart. The acquisitions could add around $8 million to its annual revenue. Earlier, the company had acquired Proack Security and Cycura, strengthening its capabilities to safeguard sensitive data and maintain robust security systems.
Besides, WELL Health is investing in AI (artificial intelligence) technology to develop new products and services that could enhance patients’ experience, thus driving organic growth. Along with these initiatives, the company also focuses on improving its profitability. So, it has implemented a cost-optimization program to improve its operational efficiency and drive profitability. Meanwhile, WELL Health has also strengthened its financial position by refinancing a credit facility of $300 million at favourable terms. So, it is well-equipped to fund its growth initiatives. The company expects to lower its debt levels, leverage ratio, and interest expenses this year. So, these initiatives could boost its financials.
Meanwhile, WELL Health’s management expects its top line to be $950-$970 million this year, with the midpoint representing a 24% increase from the previous year. Amid top-line growth, its adjusted EBITDA could grow 15%.
Investors’ takeaway
Amid the recent selloff, WELL Health’s valuation has declined to enticing levels, with its NTM (next-12-month) price-to-sales and NTM price-to-earnings multiples at 0.9 and 12.8, respectively. Despite the near-term weakness, I believe investors with a longer investment horizon can start accumulating the stock to earn superior returns in the long run.
...
https://www.fool.ca/2024/04/24/down-15-since-earnings-is-wel…
Despite the near-term weakness, WELL Health offers excellent buying opportunities for long-term investors, given the expanding addressable markets and attractive valuation.
WELL Health Technologies (TSX:WELL) is a tech-enabled healthcare company that focuses on technologies and services to aid healthcare providers in improving patient outcomes. Last month, the company reported underwhelming fourth-quarter earnings, with its adjusted net income declining by 10%. The company’s lower-than-expected 2024 guidance weighed on its stock price. It has lost 14.6% of its stock value since reporting its fourth-quarter earnings and is trading at a discount of 40% compared to its 52-week high.
So, let’s assess whether the recent correction offers any buying opportunities in the stock by looking at its recent performance and growth prospects.
WELL’s fourth-quarter performance
In the fourth quarter, WELL Health’s revenue grew 48% to $231.2 million. The acquisitions over the last four quarters, solid organic growth in its virtual businesses, and higher patient visits at its primary care drove its top line. Amid the top-line growth, its gross profits increased by 26%. However, its gross margins fell 760 basis points to 43.7% amid increased lower-margin recruitment-related revenue.
Meanwhile, the company’s net income increased from $22.1 million to $33.8 million. However, after removing special items, its adjusted net income stood at $11.16 million, representing a 10.7% decline from the previous year’s quarter. Also, its adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) stood at $30.8 million, a 13% increase from the previous year’s quarter. The company ended 2023 with cash and cash equivalents of $43.4 million, representing an 11.2% decline from the prior year’s quarter. Now, let’s look at its growth prospects.
WELL’s growth prospects
The digitization of clinical procedures and the growing popularity of virtual healthcare services have created a multi-year growth potential for WELL Health. Meanwhile, the Vancouver-based company has continued its expansion by signing an agreement to acquire 10 primary care medical clinics in Ontario and British Columbia from Shoppers Drug Mart. The acquisitions could add around $8 million to its annual revenue. Earlier, the company had acquired Proack Security and Cycura, strengthening its capabilities to safeguard sensitive data and maintain robust security systems.
Besides, WELL Health is investing in AI (artificial intelligence) technology to develop new products and services that could enhance patients’ experience, thus driving organic growth. Along with these initiatives, the company also focuses on improving its profitability. So, it has implemented a cost-optimization program to improve its operational efficiency and drive profitability. Meanwhile, WELL Health has also strengthened its financial position by refinancing a credit facility of $300 million at favourable terms. So, it is well-equipped to fund its growth initiatives. The company expects to lower its debt levels, leverage ratio, and interest expenses this year. So, these initiatives could boost its financials.
Meanwhile, WELL Health’s management expects its top line to be $950-$970 million this year, with the midpoint representing a 24% increase from the previous year. Amid top-line growth, its adjusted EBITDA could grow 15%.
Investors’ takeaway
Amid the recent selloff, WELL Health’s valuation has declined to enticing levels, with its NTM (next-12-month) price-to-sales and NTM price-to-earnings multiples at 0.9 and 12.8, respectively. Despite the near-term weakness, I believe investors with a longer investment horizon can start accumulating the stock to earn superior returns in the long run.
...
https://www.fool.ca/2024/04/24/down-15-since-earnings-is-wel…
So war fleißig und habe meinen Einstieg auf knappe 2,5€ gedrückt. 😀 denke das ist relativ save. Wenn man bedenkt welche Beteiligung Well Health Tech an HealWell AI hat. Da ist der jetzige Börsenwert schon abgedeckt.
Trading Spotlight
WELL HEALTH ACQUIRES 10 PRIMARY CARE MEDICAL CLINICS FROM SHOPPERS DRUG MART
Well says it will integrate digital workflows, patient engagement tech, and AI tools into the clinics once acquired.
Vancouver-based digital healthcare company Well Health Technologies has acquired 10 primary-care medical clinics across British Columbia (BC) and Ontario from Loblaw-owned Shoppers Drug Mart.
The deal, made through its subsidiary the Well Health Clinic Network, will see Well Health acquire all primary care medical clinics operated by Shoppers Drug Mart under The Health Clinic by Shoppers banner. The banner is made up of 35 physicians across four clinics in BC and six clinics in Ontario, according to Well Health, and will be rebranded under the Well Clinic name.
Well Health said it expects the new clinics to add approximately $8 million in annual revenue, and will look to staff them with more physicians. Financial terms of the deal were not disclosed.
...
https://betakit.com/well-health-acquires-10-primary-care-med…
Well says it will integrate digital workflows, patient engagement tech, and AI tools into the clinics once acquired.
Vancouver-based digital healthcare company Well Health Technologies has acquired 10 primary-care medical clinics across British Columbia (BC) and Ontario from Loblaw-owned Shoppers Drug Mart.
The deal, made through its subsidiary the Well Health Clinic Network, will see Well Health acquire all primary care medical clinics operated by Shoppers Drug Mart under The Health Clinic by Shoppers banner. The banner is made up of 35 physicians across four clinics in BC and six clinics in Ontario, according to Well Health, and will be rebranded under the Well Clinic name.
Well Health said it expects the new clinics to add approximately $8 million in annual revenue, and will look to staff them with more physicians. Financial terms of the deal were not disclosed.
...
https://betakit.com/well-health-acquires-10-primary-care-med…
Heute super Zahlenwerk von UnitedHealth das könnte hier auch helfen, denke ich!!!!
Was hier noch keiner auf dem Schirm hat, ist das Well noch 90% der Anteile von Well AI hält. Diese werden gerade mit 100.000.000 bewertet. Da schlummert ein Vermögen 😀
Hier findet sich wohl der Grund für die schwache Performance. US-Krankenversicherer erwischten am Dienstag einen ganz schwachen Handelstag. Grund für die ungewöhnlich heftigen Kursverluste bei UnitedHealth und Humana war die jüngste Entscheidung der US-Gesundheitsbehörde CMS.
Oder die Zahlen waren nicht so gut wie erwartet. In Wahljahren läuft der Gesundheitssektor in den USA meist nicht gut, vllt auch ein Grund. Für mich jedenfalls kein Grund auszusteigen, ich habe bei 2,60 EUR nachgelegt.
WELL Health keeps $8.50 target at PI
Following the company’s fourth quarter results, PI Financial analyst Jason Zandberg has maintained his bullish price target on WELL Health (WELL Health Stock Quote, Chart, News, Analysts, Financials TSX:WELL).
On March 21, WELL reported its Q4 and fiscal 2023 results. In the fourth quarter, the company posted Adjusted EBITDA of $30.8-million on revenue of $231.2-million, a topline that was up 48 per cent over the same period a year prior.
“We had an outstanding year in 2023 with record revenue, adjusted EBITDA [earnings before interest, taxes, depreciation and amortization], net income and patient visits,” CEO Hamed Shahbazi said. “I am proud to announce that with the inclusion of growth associated with our clinic absorption program where Well is attracting clinics to its network for nominal consideration, we achieved organic growth of 15 per cent and overall revenue growth of 36 per cent in 2023 driven by strong operating results across all our business units.
...
In a research update to clients March 22, Zandberg maintained his “Buy” rating and $8.50 target on WELL, implying a return of 123.1% at the time of publication.
The analyst described the results as “mostly positive”, noting the minor dip in EBITDA was offset by revenue increases.
...
Zandberg thinks WELL will post Adjusted EBITDA of $124.9-million on revenue of $955.0-million in fiscal 2024. He expects those numbers will improve to Adjusted EBITDA of $150.0-million on a topline of $1.06-billion the following year.
...
https://www.cantechletter.com/2024/03/well-health-keeps-8-50…
WELL Health keeps $8.50 target at PI
Following the company’s fourth quarter results, PI Financial analyst Jason Zandberg has maintained his bullish price target on WELL Health (WELL Health Stock Quote, Chart, News, Analysts, Financials TSX:WELL).
On March 21, WELL reported its Q4 and fiscal 2023 results. In the fourth quarter, the company posted Adjusted EBITDA of $30.8-million on revenue of $231.2-million, a topline that was up 48 per cent over the same period a year prior.
“We had an outstanding year in 2023 with record revenue, adjusted EBITDA [earnings before interest, taxes, depreciation and amortization], net income and patient visits,” CEO Hamed Shahbazi said. “I am proud to announce that with the inclusion of growth associated with our clinic absorption program where Well is attracting clinics to its network for nominal consideration, we achieved organic growth of 15 per cent and overall revenue growth of 36 per cent in 2023 driven by strong operating results across all our business units.
...
In a research update to clients March 22, Zandberg maintained his “Buy” rating and $8.50 target on WELL, implying a return of 123.1% at the time of publication.
The analyst described the results as “mostly positive”, noting the minor dip in EBITDA was offset by revenue increases.
...
Zandberg thinks WELL will post Adjusted EBITDA of $124.9-million on revenue of $955.0-million in fiscal 2024. He expects those numbers will improve to Adjusted EBITDA of $150.0-million on a topline of $1.06-billion the following year.
...
https://www.cantechletter.com/2024/03/well-health-keeps-8-50…
Durchsuchen
21.03.24 · IRW Press · WELL Health Technologies |
30.11.23 · IRW Press · WELL Health Technologies |
14.11.23 · IRW Press · CAD/USD |